SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Revenue Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual revenue in 2023 was 898.6 Million EUR , up 9.43% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly revenue in 2024 Q2 was 234.2 Million EUR , up 0.95% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a annual revenue of 821.14 Million EUR in annual revenue 2022, up 26.59% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a annual revenue of 648.66 Million EUR in annual revenue 2021, up 11.03% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly revenue of 234.2 Million EUR for 2024 Q2, up 0.95% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly revenue of 254 Million EUR for 2024 Q3, up 8.28% from previous quarter.

Annual Revenue Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Revenue of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Revenue Revenue Growth
2023 898.6 Million EUR 9.43%
2022 821.14 Million EUR 26.59%
2021 648.66 Million EUR 11.03%
2020 584.22 Million EUR 0.0%

Peer Revenue Comparison of SCHOTT Pharma AG & Co. KGaA

Name Revenue Revenue Difference
Carl Zeiss Meditec AG 2.08 Billion EUR 56.99%
Fielmann Aktiengesellschaft 1.96 Billion EUR 54.364%
Gerresheimer AG 1.99 Billion EUR 54.855%
Sartorius Aktiengesellschaft 3.39 Billion EUR 73.537%
Sartorius Aktiengesellschaft 3.39 Billion EUR 73.537%